Global Information
회사소개 | 문의 | 비교리스트

세계의 콜레스테롤 검사 시장 : 예측과 기회(-2025년)

Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By End-User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934745
페이지 정보 영문 111 Pages
가격
US $ 4,450 ₩ 5,094,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,239,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,819,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 콜레스테롤 검사 시장 : 예측과 기회(-2025년) Global Cholesterol Testing Market By Indication, By Product, By End-Product, By Test, By Age, By End-User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 111 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 콜레스테롤 검사 시장은 심혈관 질환 및 비만 위험 증가, 노인 인구 증가, 예방의료 인지도와 채용 증가 등의 이유로 인해 예측기간 동안 빠른 속도로 성장할 것으로 예상됩니다 .

세계의 콜레스테롤 검사(Cholesterol Testing) 시장을 부문 및 지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 코로나19(COVID-19)가 세계 콜레스테롤 검사 시장에 미치는 영향

제4장 개요

제5장 고객의 견해

제6장 세계의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별(동맥경화, 당뇨병, 비만 등)
    • 제품별(테스트 스트립, 테스트 키트(Without meter, With meter, Mail-in))
    • 최종 생성물별(총콜레스테롤, HDL 콜레스테롤, LDL 콜레스테롤, 트리글리세리드)
    • 검사별(Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping Test, Apolipoprotein CI 등)
    • 연령별(사춘기 이전, 사춘기, 성인기 이전)
    • 최종사용자별(병원 및 클리닉, 홈케어 등)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별
    • 제품별
    • 최종 생성물별
    • 유형별
    • 연령별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제8장 유럽의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별
    • 제품별
    • 최종 생성물별
    • 유형별
    • 연령별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 러시아
    • 스페인

제9장 북미의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별
    • 제품별
    • 최종 생성물별
    • 유형별
    • 연령별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별
    • 제품별
    • 최종 생성물별
    • 유형별
    • 연령별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 콜레스테롤 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 증후별
    • 제품별
    • 최종 생성물별
    • 유형별
    • 연령별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 경쟁 상황

  • 경쟁 전망
  • 기업 개요(주요 기업)
    • Abaxis, Inc.
    • Abbott Laboratories
    • Akers Biosciences, Inc.
    • Beckman Coulter, Inc.
    • Bio-Reference Laboratories
    • Boston Heart Diagnostics Corporation
    • Cell Biolabs, Inc
    • Clinical Reference Laboratory, Inc.
    • F. Hoffmann-La Roche Ltd
    • Prima Lab SA
    • PTS Diagnostics
    • Quest Diagnostics
    • Randox Laboratories
    • Sekisui Diagnostics, LLC
    • Siemens Healthineers
    • Sigma-Aldrich Corporation
    • Spectra Laboratories
    • SpectraCell Laboratories, Inc
    • Thermo Fisher Scientific
    • Unilabs

제15장 전략적 권장사항

제16장 면책조항

LSH 20.06.05

Global cholesterol testing market is expected to grow at brisk rate during the forecast period owing reasons like surge in risk of cardiovascular diseases & obesity, surge in aging population and rising awareness and adoption of preventive healthcare. Additionally, increase in healthcare expenditure by various governments around the world is also driving the cholesterol testing market. Furthermore, rapid technological advancements in cholesterol testing and growing focus on developing new products are the key factors contributing to the constant growth of technological advancements in cholesterol testing market globally.

A complete cholesterol test is also called a lipid panel or lipid profile. The test can be used to measure the amount of "good" and "bad" cholesterol and triglycerides, a type of fat, in a person's blood. Too much LDL cholesterol in blood may put the person at risk for heart disease and other serious conditions. High LDL levels can cause the build-up of plaque, a fatty substance that narrows the arteries and blocks blood from flowing normally. Additionally, growing health concerns among the population is creating huge demand for cholesterol testing. Moreover, government is also trying to improve the quality of testing and thus, the cholesterol testing market is anticipated to hold a huge growth potential for the market players in the coming years.

The global cholesterol testing market is segmented based indication, product, end product, test, age, end-user and region. Based on end-user, the market is segment between hospitals & clinics, homecare and others. In 2019, hospitals & clinics segment held the largest market share owing to increasing number of patients performed in hospitals and rising number of hospitals and clinics around the world with advanced laboratory infrastructure.

Major players operating in the global cholesterol testing market include Abaxis, Inc., Abbott Laboratories, Akers Biosciences, Inc., Beckman Coulter, Inc., Bio-Reference Laboratories, Boston Heart Diagnostics Corporation, Cell Biolabs, Inc, Clinical Reference Laboratory, Inc., F. Hoffmann-La Roche Ltd, Prima Lab SA, PTS Diagnostics, Quest Diagnostics, Randox Laboratories, Sekisui Diagnostics, LLC, Siemens Healthineers, Sigma-Aldrich Corporation, Spectra Laboratories, SpectraCell Laboratories, Inc, Thermo Fisher Scientific, Unilabs and others. The market players are focusing on various strategic initiatives like regional expansion, new product development and strategic collaborations and partnerships.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global cholesterol testing market.
  • To classify and forecast global cholesterol testing market based on indication, product, end product, test, age, end-user, company and regional distribution.
  • To identify drivers and challenges for global cholesterol testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cholesterol testing market.
  • To conduct pricing analysis for global cholesterol testing market.
  • To identify and analyze the profile of leading players operating in global cholesterol testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global cholesterol testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Cholesterol testing companies, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cholesterol testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global cholesterol testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Atherosclerosis

Diabetes

Obesity

Others

  • Market, By Product:

Test Strips

Test Kits

Without meter

With meter

Mail-in

  • Market, By End-Product:

Total cholesterol

High-density lipoprotein (HDL) cholesterol

Low-density lipoprotein (LDL) cholesterol

Triglycerides

  • Market, By Test:

Lipid Panel Test/Complete Lipid Profile

Apolipoprotein B Test

Apolipoprotein A-1 Test

Apoe Genotyping Test

Apolipoprotein CII

Others

  • Market, By Age:

Before Puberty

Puberty

Adulthood

  • Market, By End-User:

Hospitals & Clinics

Homecare

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cholesterol testing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Cholesterol Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Cholesterol Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Atherosclerosis, Diabetes, Obesity, Others)
    • 6.2.2. By Product (Test Strips, Test Kits (Without meter, With meter, Mail-in))
    • 6.2.3. By End-Product (Total cholesterol, High-density lipoprotein (HDL) cholesterol, Low-density lipoprotein (LDL) cholesterol, Triglycerides)
    • 6.2.4. By Test (Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping Test, Apolipoprotein CII, Others)
    • 6.2.5. By Age (Before Puberty, Puberty, Adulthood)
    • 6.2.6. By End-User (Hospitals & Clinics, Homecare, Others)
    • 6.2.7. By Company (2019)
    • 6.2.8. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Cholesterol Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Product
    • 7.2.3. By End-Product
    • 7.2.4. By Type
    • 7.2.5. By Age
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Cholesterol Testing Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Product
        • 7.4.1.2.3. By End-Product
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Age
        • 7.4.1.2.6. By End-User
    • 7.4.2. India Cholesterol Testing Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Product
        • 7.4.2.2.3. By End-Product
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Age
        • 7.4.2.2.6. By End-User
    • 7.4.3. Japan Cholesterol Testing Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Product
        • 7.4.3.2.3. By End-Product
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Age
        • 7.4.3.2.6. By End-User
    • 7.4.4. South Korea Cholesterol Testing Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Indication
        • 7.4.4.2.2. By Product
        • 7.4.4.2.3. By End-Product
        • 7.4.4.2.4. By Type
        • 7.4.4.2.5. By Age
        • 7.4.4.2.6. By End-User
    • 7.4.5. Singapore Cholesterol Testing Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Indication
        • 7.4.5.2.2. By Product
        • 7.4.5.2.3. By End-Product
        • 7.4.5.2.4. By Type
        • 7.4.5.2.5. By Age
        • 7.4.5.2.6. By End-User
    • 7.4.6. Australia Cholesterol Testing Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Indication
        • 7.4.6.2.2. By Product
        • 7.4.6.2.3. By End-Product
        • 7.4.6.2.4. By Type
        • 7.4.6.2.5. By Age
        • 7.4.6.2.6. By End-User

8. Europe Cholesterol Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Product
    • 8.2.3. By End-Product
    • 8.2.4. By Type
    • 8.2.5. By Age
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Cholesterol Testing Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Product
        • 8.4.1.2.3. By End-Product
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Age
        • 8.4.1.2.6. By End-User
    • 8.4.2. Germany Cholesterol Testing Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Product
        • 8.4.2.2.3. By End-Product
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Age
        • 8.4.2.2.6. By End-User
    • 8.4.3. United Kingdom Cholesterol Testing Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Product
        • 8.4.3.2.3. By End-Product
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Age
        • 8.4.3.2.6. By End-User
    • 8.4.4. Italy Cholesterol Testing Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Product
        • 8.4.4.2.3. By End-Product
        • 8.4.4.2.4. By Type
        • 8.4.4.2.5. By Age
        • 8.4.4.2.6. By End-User
    • 8.4.5. Russia Cholesterol Testing Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Product
        • 8.4.5.2.3. By End-Product
        • 8.4.5.2.4. By Type
        • 8.4.5.2.5. By Age
        • 8.4.5.2.6. By End-User
    • 8.4.6. Spain Cholesterol Testing Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Product
        • 8.4.6.2.3. By End-Product
        • 8.4.6.2.4. By Type
        • 8.4.6.2.5. By Age
        • 8.4.6.2.6. By End-User

9. North America Cholesterol Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Product
    • 9.2.3. By End-Product
    • 9.2.4. By Type
    • 9.2.5. By Age
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Cholesterol Testing Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Product
        • 9.4.1.2.3. By End-Product
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Age
        • 9.4.1.2.6. By End-User
    • 9.4.2. Mexico Cholesterol Testing Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Product
        • 9.4.2.2.3. By End-Product
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Age
        • 9.4.2.2.6. By End-User
    • 9.4.3. Canada Cholesterol Testing Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Product
        • 9.4.3.2.3. By End-Product
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Age
        • 9.4.3.2.6. By End-User

10. South America Cholesterol Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Product
    • 10.2.3. By End-Product
    • 10.2.4. By Type
    • 10.2.5. By Age
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Cholesterol Testing Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Product
        • 10.4.1.2.3. By End-Product
        • 10.4.1.2.4. By Type
        • 10.4.1.2.5. By Age
        • 10.4.1.2.6. By End-User
    • 10.4.2. Argentina Cholesterol Testing Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Product
        • 10.4.2.2.3. By End-Product
        • 10.4.2.2.4. By Type
        • 10.4.2.2.5. By Age
        • 10.4.2.2.6. By End-User
    • 10.4.3. Colombia Cholesterol Testing Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Product
        • 10.4.3.2.3. By End-Product
        • 10.4.3.2.4. By Type
        • 10.4.3.2.5. By Age
        • 10.4.3.2.6. By End-User

11. Middle East and Africa Cholesterol Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Product
    • 11.2.3. By End-Product
    • 11.2.4. By Type
    • 11.2.5. By Age
    • 11.2.6. By End-User
    • 11.2.7. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Cholesterol Testing Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Product
        • 11.4.1.2.3. By End-Product
        • 11.4.1.2.4. By Type
        • 11.4.1.2.5. By Age
        • 11.4.1.2.6. By End-User
    • 11.4.2. Saudi Arabia Cholesterol Testing Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Product
        • 11.4.2.2.3. By End-Product
        • 11.4.2.2.4. By Type
        • 11.4.2.2.5. By Age
        • 11.4.2.2.6. By End-User
    • 11.4.3. UAE Cholesterol Testing Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Product
        • 11.4.3.2.3. By End-Product
        • 11.4.3.2.4. By Type
        • 11.4.3.2.5. By Age
        • 11.4.3.2.6. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Abaxis, Inc.
    • 14.2.2. Abbott Laboratories
    • 14.2.3. Akers Biosciences, Inc.
    • 14.2.4. Beckman Coulter, Inc.
    • 14.2.5. Bio-Reference Laboratories
    • 14.2.6. Boston Heart Diagnostics Corporation
    • 14.2.7. Cell Biolabs, Inc
    • 14.2.8. Clinical Reference Laboratory, Inc.
    • 14.2.9. F. Hoffmann-La Roche Ltd
    • 14.2.10. Prima Lab SA
    • 14.2.11. PTS Diagnostics
    • 14.2.12. Quest Diagnostics
    • 14.2.13. Randox Laboratories
    • 14.2.14. Sekisui Diagnostics, LLC
    • 14.2.15. Siemens Healthineers
    • 14.2.16. Sigma-Aldrich Corporation
    • 14.2.17. Spectra Laboratories
    • 14.2.18. SpectraCell Laboratories, Inc
    • 14.2.19. Thermo Fisher Scientific
    • 14.2.20. Unilabs

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q